TRex Bio, Inc. TRXB
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Net Income | -14.65M | -14.65M | |||
| Total Depreciation and Amortization | -149.50K | -149.50K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 172.00K | 172.00K | |||
| Change in Net Operating Assets | 1.12M | 1.12M | |||
| Cash from Operations | -13.51M | -13.51M | |||
| Capital Expenditure | -5.50K | -5.50K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -14.27M | -14.27M | |||
| Cash from Investing | -14.28M | -14.28M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 53.00K | 53.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | 25.00M | 25.00M | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -338.50K | -338.50K | |||
| Cash from Financing | 24.71M | 24.71M | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -3.07M | -3.07M | |||